Background: Inhalational anthrax, caused by the bacterium Bacillus anthracis, is a rare but serious disease. This article provides an overview of the long-term pulmonary complications associated with this condition. Key Points: The study highlights that inhalational anthrax can lead to severe respiratory issues, which may persist long after the initial infection. Patients often experience chronic respiratory symptoms, including cough and shortness of breath. Radiographic findings frequently show persistent abnormalities in the lungs. Findings: Treatment primarily involves antibiotics and supportive care, but the long-term management of pulmonary complications remains challenging. The article emphasizes the importance of early detection and ongoing monitoring of affected individuals to manage these chronic symptoms effectively. Conclusion: The study underscores the need for further research into the long-term effects of inhalational anthrax on pulmonary health and the development of more effective treatment protocols to address these complications.